Fibrinogen Blood Test: Normal Range, High & Low Levels

Fibrinogen is a protein synthesized by the liver that plays a crucial role in blood clotting and hemostasis. Reduced fibrinogen levels may indicate liver disorders, coagulation disorders, or specific medical conditions such as dysfibrinogenemia. Elevated fibrinogen levels are associated with increased risk of thromboembolism and cardiovascular disease. Monitoring fibrinogen levels is important for patients with bleeding disorders or those at increased risk for blood clots.

Understanding Fibrinogen and Blood Clotting

Fibrinogen is the precursor to fibrin, the protein that forms the structural backbone of blood clots. When thrombin acts on fibrinogen, it converts it to fibrin monomers that polymerize to form clot strands. This process is essential for hemostasis and preventing excessive bleeding.

Fibrinogen Reference Values and Interpretation

Normal fibrinogen levels in adults typically range between 200 and 400 mg/dL (2.0 to 4.0 g/L). Fibrinogen is a protein synthesized by the liver that plays a crucial role in blood clotting and hemostasis. Low fibrinogen (<200 mg/dL) indicates bleeding risk, while elevated levels (>400 mg/dL) are associated with thrombotic and cardiovascular risk.

Low Fibrinogen Levels and Bleeding Risk

Hypofibrinogenemia (low fibrinogen) can result from liver disease, disseminated intravascular coagulation (DIC), excessive fibrinolysis, or genetic fibrinogen disorders. Patients with low fibrinogen are at increased risk of bleeding and may require transfusion of fibrinogen concentrates.

High Fibrinogen and Cardiovascular Risk

Elevated fibrinogen is an independent risk factor for cardiovascular disease, stroke, and thromboembolism. Fibrinogen contributes to blood viscosity and platelet aggregation, increasing thrombotic risk. Chronic inflammation can lead to elevated fibrinogen as part of the acute phase response.

When Fibrinogen Testing is Needed

Fibrinogen testing is indicated in patients with bleeding disorders, those on anticoagulant therapy, patients with liver disease, individuals at cardiovascular risk, or those suspected of DIC. Serial fibrinogen measurements can monitor disease progression or treatment response.

What the fibrinogen test measures and how it’s done

A fibrinogen test is a blood test that tells your healthcare provider how much fibrinogen is circulating in your blood. Fibrinogen is a protein produced by the liver that helps stop bleeding by enabling blood clots to form, so measuring its concentration gives a direct read on one of the building blocks of the clotting system.

The test itself is straightforward. A phlebotomist draws blood from a vein, usually in the arm. No special preparation is needed — you do not need to fast, change medications, or follow other instructions before the appointment unless your provider tells you otherwise. When the needle is inserted, some people feel moderate pain while others feel only a prick or stinging sensation. Afterward, the puncture site may throb briefly or develop slight bruising, which usually resolves quickly.

This test is also called by several other names you may see on a lab order or results portal. Common synonyms include serum fibrinogen, plasma fibrinogen, Factor I, and hypofibrinogenemia test. They all refer to the same measurement, even though laboratories may use slightly different methods or specimen types — which is why your specific reference range is printed on the report you receive.

Who typically gets this test

Your provider may order a fibrinogen test if you have problems with blood clotting, such as excessive bleeding or symptoms suggesting a bleeding disorder. It is also used during pregnancy in specific situations, including when the placenta separates from the uterine wall (placental abruption). The test is not part of standard checkups for people without symptoms or known clotting concerns.

How to interpret your results

Fibrinogen results are reported as a concentration in plasma, and what counts as normal depends on the laboratory that ran your sample. Always read your number against the reference range printed on your own lab report — that range is the most reliable comparison point for your result.

Quick reference for typical adult ranges:

What the result shows	General interpretation
Within the lab’s reference range	Fibrinogen production and consumption are balanced
Below the lab’s reference range	Insufficient fibrinogen; may reflect consumption, breakdown, or deficiency
Above the lab’s reference range	Excess fibrinogen; may reflect inflammation, infection, or other acute response

A result outside the reference range does not by itself diagnose a condition. Abnormal fibrinogen can reflect several different processes. These include the body using up fibrinogen too quickly (as in disseminated intravascular coagulation, or DIC), inherited or acquired fibrinogen deficiency, fibrinolysis (the breakdown of fibrin), heavy bleeding, and certain conditions such as infection or inflammation. Your clinician interprets the number in context — alongside your symptoms, your medical history, and any other coagulation tests.

Why labs differ

Normal value ranges may vary slightly among different labs, and some labs use different measurements or test different specimens. That is not a sign of inaccuracy. It reflects differences in how each laboratory has calibrated its reference population. Talk to your provider about the meaning of your specific test results — they have access to the full clinical picture and the assay your sample actually went through.

Fibrinogen, inflammation, and cardiovascular research

Beyond its role in stopping bleeding, fibrinogen has been studied as a possible marker of long-term cardiovascular risk. The reason is that fibrinogen rises in response to inflammation — medlineplus explicitly lists infection and inflammation among the conditions that can produce abnormal fibrinogen results. That overlap between clotting protein and inflammatory marker is what put fibrinogen on cardiologists’ radar in the first place.

What the largest meta-analysis found

The most cited evidence comes from the Fibrinogen Studies Collaboration, an individual-participant meta-analysis published in JAMA in 2005. The study pooled data on 154,211 participants across 31 prospective studies, with 1.38 million person-years of follow-up, 6,944 first nonfatal heart attacks or strokes, and 13,210 deaths. Participants with a known prior history of cardiovascular disease were excluded.

The headline finding: an approximately log-linear association between usual plasma fibrinogen levels and risk of coronary heart disease, stroke, other vascular mortality, and nonvascular mortality, with no evidence of a threshold within the range studied. Specifically, the age- and sex-adjusted hazard ratios per 1 g/L higher usual fibrinogen were:

Coronary heart disease: 2.42 (95% CI 2.24-2.60)
Stroke: 2.06 (95% CI 1.83-2.33)
Other vascular mortality: 2.76 (95% CI 2.28-3.35)
Nonvascular mortality: 2.03 (95% CI 1.90-2.18)

How to read those numbers

Two caveats matter. First, after further adjustment for other established vascular risk factors, the hazard ratios for coronary heart disease and stroke were reduced to about 1.8 — meaning some of fibrinogen’s apparent risk signal overlaps with conditions that travel with it. Second, the authors explicitly concluded that assessing any causal role of elevated fibrinogen requires additional research. The association is real and reproducible. Whether lowering fibrinogen would directly lower cardiovascular risk is a separate, unsettled question.

A subset analysis is also informative. In 7,011 participants with available C-reactive protein values, the fibrinogen-CHD finding was essentially unchanged after adjusting for CRP. That suggests fibrinogen is not simply a stand-in for inflammation captured by hs-CRP. The associations also did not differ substantially by sex, smoking, blood pressure, or blood lipid levels.

Fibrinogen in pregnancy and special populations

Pregnancy is one of the situations in which fibrinogen testing is specifically used. MedlinePlus notes that the test may be performed during pregnancy if the placenta separates from its attachment to the uterus wall — a condition called placental abruption. Abruption is an obstetric emergency that can consume clotting factors rapidly, and tracking fibrinogen helps the obstetric team gauge how much clotting reserve remains.

Outside of abruption, fibrinogen may be measured in pregnancy whenever there is concern about bleeding or about a coagulopathy developing — for example, as part of evaluating a patient with excessive bleeding symptoms. The clinical question is always the same as in nonpregnant patients: is the body making enough fibrinogen, and is it being consumed faster than the liver can replace it?

People with known bleeding disorders

For someone who already has a diagnosed bleeding disorder, the fibrinogen test carries one practical caveat worth knowing. The blood draw itself is low-risk for most people, but the risk of excessive bleeding from the puncture site is slightly greater in patients with bleeding disorders than in those without. The phlebotomist may apply pressure for longer than usual, and a small pressure bandage may be left in place. This is a routine accommodation, not a sign that something has gone wrong.

Fibrinogen is rarely interpreted in complete isolation. Because it is one specific protein in a much larger clotting system, your provider will typically read the result alongside other markers when investigating a clotting or bleeding problem. MedlinePlus describes the test as part of the workup for problems with blood clotting, such as excessive bleeding.

On Symptomatik you can read about several of the other tests commonly used in coagulation workups:

Prothrombin time (PT) — measures one arm of the clotting cascade
Activated partial thromboplastin time (aPTT) — measures a different arm of the same cascade
D-dimer — a fragment released when clots break down
Platelet count — the cellular component of clotting
hs-CRP — a separate marker of systemic inflammation

Reading these results together gives a far more complete picture than any single number on its own. Your clinician chooses which combination makes sense based on the question being asked — bleeding workup, suspected DIC, pregnancy complication, or cardiovascular evaluation.

Frequently asked questions

What is fibrinogen and what does the test measure?

Fibrinogen is a protein produced by the liver that helps blood clots form and stop bleeding. The fibrinogen test measures how much of this protein is circulating in your blood, which gives your healthcare provider information about your clotting system.

Do I need to fast before a fibrinogen test?

No. No special preparation is needed before a fibrinogen blood test. Cleveland Clinic similarly notes that you typically do not need to follow special instructions to prepare. If your provider asks for additional preparation, that direction is specific to your situation.

Why is fibrinogen sometimes checked in pregnancy?

The fibrinogen test may be performed during pregnancy if the placenta separates from its attachment to the uterus wall, a condition called placental abruption. It can also be used when evaluating excessive bleeding or other clotting concerns during pregnancy.

Is the blood draw risky?

There is little risk involved in having your blood taken. Possible side effects are minor. They may include excessive bleeding from the puncture site, fainting or feeling lightheaded, multiple needle punctures to locate a vein, hematoma (blood pooling under the skin), and a slight risk of infection any time the skin is broken.

Why does my lab’s normal range look different from what I’ve read online?

Normal value ranges may vary slightly among different labs because some laboratories use different measurements or test different specimens. The most reliable comparison is the reference range printed on your own lab report. If anything is unclear, your provider can interpret the result against the specific assay used.

What other names might I see for this test?

Fibrinogen testing may be listed on lab orders or portals as serum fibrinogen, plasma fibrinogen, Factor I, or hypofibrinogenemia test. They all refer to a measurement of fibrinogen in the blood, though laboratories may report slightly different units or use different methods.

Does fibrinogen always go up with inflammation?

Fibrinogen can rise in certain conditions such as infection or inflammation. That is one of the reasons researchers have studied it alongside other cardiovascular risk markers. Fibrinogen is associated with risk of coronary heart disease and stroke in large prospective studies, though whether elevated levels directly cause that risk requires additional research.

When to talk to your doctor

A fibrinogen result is one piece of a clinical picture, not a verdict. The most useful question to bring to a clinician is not “is this number normal” but “what does this number mean given everything else going on with me.” Reach out to your healthcare provider in any of the following situations:

You have unexplained or excessive bleeding — easy bruising, prolonged bleeding from minor cuts, frequent nosebleeds, or heavy menstrual bleeding that has changed from your usual pattern
After your blood draw you notice excessive bleeding, fainting, lightheadedness, or a hematoma at the puncture site, particularly if symptoms do not resolve within a few hours
You are pregnant and experience sudden abdominal pain, vaginal bleeding, or other symptoms that could suggest placental abruption — this is an emergency situation in which fibrinogen testing may be part of the workup
You have a known bleeding disorder and need any procedure or surgery; ask whether your fibrinogen level should be checked beforehand, since people with bleeding disorders have a slightly higher risk of excessive bleeding from venipuncture and other procedures
Your fibrinogen result is outside the reference range on your lab report and you have not yet discussed it with your provider; abnormal results can reflect DIC, fibrinogen deficiency, fibrinolysis, hemorrhage, or infection and inflammation, and the right next step depends on which is suspected
You have symptoms of a bleeding disorder — Cleveland Clinic specifically identifies these as a reason your provider might order or repeat the test

If your provider has already prescribed treatment to raise a low fibrinogen level, follow up as scheduled so the response can be tracked over time. And if you receive a result that worries you, the right next step is almost always a conversation with the clinician who knows your history, not a self-diagnosis from a single number.

References

Last reviewed: 2026-05-13